Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-062132
Filing Date
2025-06-24
Accepted
2025-06-24 16:39:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10633
2 EXHIBIT 1 tm2518800d1_ex1.htm EX-99.1 5508
  Complete submission text file 0001104659-25-062132.txt   17997
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
RIVERVIEW GROUP LLC (Filed by) CIK: 0001273091 (see all company filings)

EIN.: 980330397 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Subject) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95084 | Film No.: 251069732
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)